Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Stokes

Showing results (611-620 of 678) with videos related to

Pageof 68
Sort By:
The Journal of Allergy and Clinical Immunology|January 15, 2018
Glucagon-like peptide 1 signaling inhibits allergen-induced lung IL-33 release and reduces group 2 innate lymphoid cell cytokine production in vivoShinji Toki, Kasia Goleniewska, Sara Reiss, et al.
The Journal of Allergy and Clinical Immunology|August 14, 2025
Prostaglandin I<sub>2</sub> signaling restrains Treg cell ST2 expression by repressing β-catenin in allergic airway inflammationAllison E Norlander, Masako Abney, Jian Zhang, et al.
Journal of Virology|September 16, 2004
Signaling through the prostaglandin I2 receptor IP protects against respiratory syncytial virus-induced illnessKoichi Hashimoto, Barney S Graham, Mark W Geraci, et al.
Immunohorizons|July 11, 2022
Selective Pharmaceutical Inhibition of PARP14 Mitigates Allergen-Induced IgE and Mucus Overproduction in a Mouse Model of Pulmonary Allergic ResponseAlex M Eddie, Kevin W Chen, Laurie B Schenkel, et al.
The Journal of Antimicrobial Chemotherapy|April 2, 2016
Biological profiling of novel tricyclic inhibitors of bacterial DNA gyrase and topoisomerase IVVictoria J Savage, Cédric Charrier, Anne-Marie Salisbury, et al.
Journal of Virology|February 13, 2009
A chimeric A2 strain of respiratory syncytial virus (RSV) with the fusion protein of RSV strain line 19 exhibits enhanced viral load, mucus, and airway dysfunctionMartin L Moore, Michael H Chi, Cindy Luongo, et al.
American Journal of Respiratory and Critical Care Medicine|September 18, 2015
Prostaglandin I2 Signaling and Inhibition of Group 2 Innate Lymphoid Cell ResponsesWeisong Zhou, Shinji Toki, Jian Zhang, et al.
The Journal of Allergy and Clinical Immunology|March 14, 2022
Exclusive breast-feeding, the early-life microbiome and immune response, and common childhood respiratory illnessesChristian Rosas-Salazar, Meghan H Shilts, Zheng-Zheng Tang, et al.
The Journal of Allergy and Clinical Immunology|July 22, 2014
Cyclooxygenase inhibition abrogates aeroallergen-induced immune tolerance by suppressing prostaglandin I2 receptor signalingWeisong Zhou, Kasia Goleniewska, Jian Zhang, et al.
Journal of Virology|April 8, 2011
Differential pathogenesis of respiratory syncytial virus clinical isolates in BALB/c miceKate L Stokes, Michael H Chi, Kaori Sakamoto, et al.
Pageof 68

Showing results (611-620 of 678) with videos related to

Sort By:
Pageof 68
The Journal of Allergy and Clinical Immunology|January 15, 2018
Glucagon-like peptide 1 signaling inhibits allergen-induced lung IL-33 release and reduces group 2 innate lymphoid cell cytokine production in vivoShinji Toki, Kasia Goleniewska, Sara Reiss, et al.
The Journal of Allergy and Clinical Immunology|August 14, 2025
Prostaglandin I<sub>2</sub> signaling restrains Treg cell ST2 expression by repressing β-catenin in allergic airway inflammationAllison E Norlander, Masako Abney, Jian Zhang, et al.
Journal of Virology|September 16, 2004
Signaling through the prostaglandin I2 receptor IP protects against respiratory syncytial virus-induced illnessKoichi Hashimoto, Barney S Graham, Mark W Geraci, et al.
Immunohorizons|July 11, 2022
Selective Pharmaceutical Inhibition of PARP14 Mitigates Allergen-Induced IgE and Mucus Overproduction in a Mouse Model of Pulmonary Allergic ResponseAlex M Eddie, Kevin W Chen, Laurie B Schenkel, et al.
The Journal of Antimicrobial Chemotherapy|April 2, 2016
Biological profiling of novel tricyclic inhibitors of bacterial DNA gyrase and topoisomerase IVVictoria J Savage, Cédric Charrier, Anne-Marie Salisbury, et al.
Journal of Virology|February 13, 2009
A chimeric A2 strain of respiratory syncytial virus (RSV) with the fusion protein of RSV strain line 19 exhibits enhanced viral load, mucus, and airway dysfunctionMartin L Moore, Michael H Chi, Cindy Luongo, et al.
American Journal of Respiratory and Critical Care Medicine|September 18, 2015
Prostaglandin I2 Signaling and Inhibition of Group 2 Innate Lymphoid Cell ResponsesWeisong Zhou, Shinji Toki, Jian Zhang, et al.
The Journal of Allergy and Clinical Immunology|March 14, 2022
Exclusive breast-feeding, the early-life microbiome and immune response, and common childhood respiratory illnessesChristian Rosas-Salazar, Meghan H Shilts, Zheng-Zheng Tang, et al.
The Journal of Allergy and Clinical Immunology|July 22, 2014
Cyclooxygenase inhibition abrogates aeroallergen-induced immune tolerance by suppressing prostaglandin I2 receptor signalingWeisong Zhou, Kasia Goleniewska, Jian Zhang, et al.
Journal of Virology|April 8, 2011
Differential pathogenesis of respiratory syncytial virus clinical isolates in BALB/c miceKate L Stokes, Michael H Chi, Kaori Sakamoto, et al.
Pageof 68